March 12, 2010 (Miami Beach, Florida) — A new fixed-dose gel that combines the topical retinoid adapalene 0.1% and the antimicrobial benzoyl peroxide 2.5% (adapalene-BPO) is more effective at ...
The Nonprescription Drugs Advisory Committee of the US Food and Drug Administration (FDA) voted unanimously April 15 to recommend over-the-counter marketing (OTC) of adapalene gel 0.1% (Differin Gel, ...
Effaclar Adapalene Gel 0.1% Acne Treatment (La Roche-Posay) is now available over-the-counter for the treatment of acne vulgaris. Effaclar Adapalene Gel 0.1% Acne Treatment (La Roche-Posay) is now ...
One of the best anti-aging products you can find without a prescription doesn’t come in a fancy jar or cost hundreds of dollars. In fact, it’s not even best known for its incredible anti-aging effects ...
I started experiencing hormonal acne shortly after my 21st birthday. When I finally went to a dermatologist for help, I was prescribed spironolactone (my savior) and prescription-grade retinol. The ...
LAVAL, QC / ACCESSWIRE / January 30, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its dermatology business, Ortho Dermatologics, today announced the U.S. launch of CABTREO™ (clindamycin ...
Please provide your email address to receive an email when new articles are posted on . The triple-combination gel was much more evenly applied than the layered ingredients in 100% of cases. 96% of ...
LAVAL, QC / ACCESSWIRE / October 20, 2023 / Bausch Health Companies Inc. (NYSE:BHC) (TSX:BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, today announced that the U.S. Food ...
CABTREO, a prescription product, is a topical gel that is administered once daily to affected areas of the skin. Its active ingredients are the antibiotic clindamycin phosphate, the topical retinoid ...
LAVAL, QC / ACCESS Newswire / August 21, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced that ...
Prophylactic treatment for acneiform rash caused by EGFR inhibitors: Prospective randomized double-blind trial comparing daily topical chloramphenicol 3% plus prednisolone 0.5% vs chloramphenicol 3% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback